ELV
Income statement / Annual
Last year (2023), Elevance Health Inc.'s total revenue was $171.34 B,
an increase of 9.42% from the previous year.
In 2023, Elevance Health Inc.'s net income was $5.99 B.
See Elevance Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$171.34 B
|
$156.60 B
|
$138.64 B
|
$121.87 B
|
$104.21 B
|
$92.11 B
|
$90.04 B
|
$84.98 B
|
$79.24 B
|
$73.92 B
|
| Cost of Revenue |
$124.33 B |
$116.64 B |
$102.65 B |
$88.05 B |
$81.79 B |
$71.90 B |
$72.24 B |
$66.83 B |
$61.12 B |
$56.85 B |
| Gross Profit |
$47.01 B |
$39.95 B |
$35.99 B |
$33.82 B |
$22.43 B |
$20.21 B |
$17.80 B |
$18.14 B |
$18.12 B |
$17.07 B |
| Gross Profit Ratio |
0.9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$38.27 B |
$31.50 B |
$27.05 B |
$26.11 B |
$15.69 B |
$14.37 B |
$12.82 B |
$12.72 B |
$12.76 B |
$11.97 B |
| Operating Expenses |
$38.27 B |
$31.50 B |
$27.05 B |
$26.11 B |
$15.69 B |
$14.37 B |
$12.82 B |
$12.72 B |
$12.76 B |
$11.97 B |
| Cost And Expenses |
$162.60 B |
$148.14 B |
$129.69 B |
$114.16 B |
$97.48 B |
$86.27 B |
$85.05 B |
$79.56 B |
$73.88 B |
$68.82 B |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.03 B |
$851.00 M |
$798.00 M |
$784.00 M |
$746.00 M |
$753.00 M |
$739.00 M |
$723.00 M |
$653.00 M |
$600.70 M |
| Depreciation &
Amortization |
$1.75 B
|
$1.68 B
|
$1.30 B
|
$1.15 B
|
$485.00 M
|
$482.00 M
|
$279.10 M
|
$296.30 M
|
$335.90 M
|
$327.40 M
|
| EBITDA |
$10.49 B
|
$10.13 B
|
$6.00 B
|
$8.18 B
|
$7.22 B
|
$6.30 B
|
$4.98 B
|
$5.57 B
|
$5.62 B
|
$5.30 B
|
| EBITDA Ratio |
0.06 |
0.06 |
0.07 |
0.06 |
0.07 |
0.07 |
0.05 |
0.06 |
0.07 |
0.07 |
| Operating Income Ratio
|
0.78
|
0.05
|
0.06
|
0.06
|
0.06
|
0.06
|
0.06
|
0.06
|
0.07
|
0.07
|
| Total Other
Income/Expenses Net |
-$1.03 B
|
-$851.00 M
|
-$1.02 B
|
-$1.47 B
|
-$748.00 M
|
-$769.00 M
|
-$1.02 B
|
-$863.70 M
|
-$727.10 M
|
-$730.80 M
|
| Income Before Tax |
$7.72 B |
$7.60 B |
$7.93 B |
$6.24 B |
$5.99 B |
$5.07 B |
$3.96 B |
$4.56 B |
$4.63 B |
$4.37 B |
| Income Before Tax Ratio
|
0.05
|
0.05
|
0.06
|
0.05
|
0.06
|
0.06
|
0.04
|
0.05
|
0.06
|
0.06
|
| Income Tax Expense |
$1.72 B |
$1.71 B |
$1.83 B |
$1.67 B |
$1.18 B |
$1.32 B |
$121.00 M |
$2.09 B |
$2.07 B |
$1.81 B |
| Net Income |
$5.99 B |
$5.89 B |
$6.10 B |
$4.57 B |
$4.81 B |
$3.75 B |
$3.84 B |
$2.47 B |
$2.56 B |
$2.57 B |
| Net Income Ratio |
0.03 |
0.04 |
0.04 |
0.04 |
0.05 |
0.04 |
0.04 |
0.03 |
0.03 |
0.03 |
| EPS |
25.69 |
24.5583 |
25.0369 |
18.2297 |
18.8141 |
14.5292 |
14.6952 |
9.3945 |
9.7338 |
9.3139 |
| EPS Diluted |
25.22 |
24.2751 |
24.7326 |
17.9788 |
18.4672 |
14.1938 |
14.3495 |
9.2122 |
9.3807 |
8.9542 |
| Weighted Average Shares
Out |
$233.07 M
|
$240.00 M
|
$243.80 M
|
$250.80 M
|
$255.50 M
|
$254.30 M
|
$256.08 M
|
$263.75 M
|
$261.24 M
|
$268.11 M
|
| Weighted Average Shares
Out Diluted |
$237.40 M
|
$242.80 M
|
$246.80 M
|
$254.30 M
|
$260.30 M
|
$254.30 M
|
$267.80 M
|
$268.10 M
|
$272.90 M
|
$285.90 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
